Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$796K Hold
400
0.05% 144
2026
Q1
$528K Sell
400
-25
-6% -$34.3K 0.04% 180
2025
Q4
$455K Hold
425
0.03% 190
2025
Q3
$282K Hold
425
0.02% 244
2025
Q2
$282K Hold
425
0.02% 242
2025
Q1
$282K Sell
425
-51
-11% -$37.1K 0.02% 246
2024
Q4
$330K Sell
476
-31
-6% -$22.3K 0.03% 219
2024
Q3
$519K Hold
507
0.04% 168
2024
Q2
$519K Buy
507
+82
+19% +$78.8K 0.04% 168
2024
Q1
$412K Hold
425
0.03% 197
2023
Q4
$250K Hold
425
0.02% 239
2023
Q3
$250K Hold
425
0.02% 239
2023
Q2
$308K Hold
425
0.03% 223
2023
Q1
$289K Hold
425
0.03% 233
2022
Q4
$232K Buy
+425
New +$223K 0.02% 274

Other funds holding ASML

Shufro Rose & Co's ASML Position: Q2 2026 in Review

Shufro Rose & Co held its ASML (ASML) position steady in Q2 2026 at 400 shares worth $796K. The position accounts for 0.05% of the portfolio, ranked #144.

Shufro Rose & Co first reported a position in ASML in Q4 2022 and has held it in 15 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Shufro Rose & Co held 400 shares of ASML worth $796K as of Q2 2026.
  • Shufro Rose & Co left its ASML share count unchanged in Q2 2026.
  • ASML made up 0.05% of Shufro Rose & Co's portfolio in Q2 2026, its #144 holding.
  • Shufro Rose & Co first reported a position in ASML in Q4 2022 and has held it in 15 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Shufro Rose & Co's 13F filing for Q2 2026, filed 12 Aug 2026.